Food Standards Agency allows CBD company's products to remain on the market

A CBD Health Food company has received confirmation from the Food Standards Agency that its products will remain on the market.

On Thursday January 13 2022, the FSA confirmed via emails to BRITISH CANNABIS CEO, Thomas Whettem, that the evidence submitted in support of 15 dossiers, spanning over 3,000 products “has been checked and is sufficient” and that “the public list will be amended to reflect these changes”.

“Confirmation, from the FSA, that BRITISH CANNABIS will be the first manufacturer to have cannabis-derived consumer product ratified for UK sale.”

BRITISH CANNABIS’ own-brand products - CBD by BRITISH CANNABIS™ (FKA Canabidol™), Access CBD™ and CBD HEALTH™ - plus over 150 other brands that they manufacture for, look set to remain on the UK market.

Meanwhile, it is widely speculated that an as-yet undetermined number of other products, made by other manufacturers, will be removed from shelves by Trading Standards. This process looks set to begin once the FSA public lists are updated later in 2022.

Over the course of 18 months and a multi-million pound investment, BRITISH CANNABIS, has dedicated itself to ensuring the long-term continuity of all-natural, cannabis-based food supplements in the UK.

This is for the reassurance of their own consumers and of all the customers whose brands are Powered by BRITISH CANNABIS.

BRITISH CANNABIS’ CEO, Thomas Whettem, commented: “Confirmation directly from the Food Standards Agency, that BRITISH CANNABIS will be the first manufacturer in the world to have cannabis-derived consumer products ratified by the UK government, is yet another monumental breakthrough in our history.

“For years we have not just pioneered change in this industry but strived to set the bar when it comes to compliance, safety and the simple dedication to excellence we have had since day one.”